NO20000373L - Nye cyano-indol serotinin-reopptaks-inhibitorforbindelser, fremgangsmÕte for deres fremstilling og farmasøytiske sammensetninger inneholdende dem - Google Patents
Nye cyano-indol serotinin-reopptaks-inhibitorforbindelser, fremgangsmÕte for deres fremstilling og farmasøytiske sammensetninger inneholdende demInfo
- Publication number
- NO20000373L NO20000373L NO20000373A NO20000373A NO20000373L NO 20000373 L NO20000373 L NO 20000373L NO 20000373 A NO20000373 A NO 20000373A NO 20000373 A NO20000373 A NO 20000373A NO 20000373 L NO20000373 L NO 20000373L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- indole
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- CBTITARLOCZPDU-UHFFFAOYSA-N 1h-indole-2-carbonitrile Chemical compound C1=CC=C2NC(C#N)=CC2=C1 CBTITARLOCZPDU-UHFFFAOYSA-N 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 10
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 5
- 125000001072 heteroaryl group Chemical group 0.000 abstract 4
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000004419 alkynylene group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9900801A FR2788772B1 (fr) | 1999-01-26 | 1999-01-26 | Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20000373D0 NO20000373D0 (no) | 2000-01-25 |
| NO20000373L true NO20000373L (no) | 2000-07-27 |
| NO314801B1 NO314801B1 (no) | 2003-05-26 |
Family
ID=9541208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20000373A NO314801B1 (no) | 1999-01-26 | 2000-01-25 | Nye cyanoindol serotonin-reopptaks-inhibitorforbindelser og farmasöytiske sammensetninger inneholdende dem |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6239129B1 (no) |
| EP (1) | EP1023898B1 (no) |
| JP (1) | JP2000212162A (no) |
| KR (1) | KR100445389B1 (no) |
| CN (1) | CN1155570C (no) |
| AT (1) | ATE234093T1 (no) |
| AU (1) | AU761084B2 (no) |
| BR (1) | BR0000158A (no) |
| CA (1) | CA2297279C (no) |
| DE (1) | DE60001591T2 (no) |
| DK (1) | DK1023898T3 (no) |
| EA (1) | EA003146B1 (no) |
| ES (1) | ES2193923T3 (no) |
| FR (1) | FR2788772B1 (no) |
| HU (1) | HUP0000308A2 (no) |
| MX (1) | MXPA00000856A (no) |
| NO (1) | NO314801B1 (no) |
| NZ (1) | NZ502494A (no) |
| PL (1) | PL338027A1 (no) |
| SI (1) | SI1023898T1 (no) |
| ZA (1) | ZA200000336B (no) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001247562A (ja) * | 2000-03-07 | 2001-09-11 | Daicel Chem Ind Ltd | アミド化合物及びその製造方法 |
| SE0004245D0 (sv) | 2000-11-20 | 2000-11-20 | Pharmacia Ab | Novel compounds and their use |
| PL361690A1 (en) * | 2000-11-20 | 2004-10-04 | Biovitrum Ab | Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor |
| EE200300478A (et) | 2001-03-29 | 2003-12-15 | Bristol-Myers Squibb Company | Tsüklopropüülindooli derivaadid kui selektiivsed serotoniini tagasihaarde inhibiitorid |
| DK1587788T3 (da) * | 2002-09-17 | 2007-09-24 | Hoffmann La Roche | 2,7-substituerede indoler og anvendelsen deraf som 5-HT6-modulatorer |
| US7129264B2 (en) * | 2003-04-16 | 2006-10-31 | Bristol-Myers Squibb Company | Biarylmethyl indolines and indoles as antithromboembolic agents |
| WO2005056522A2 (en) * | 2003-12-04 | 2005-06-23 | National Health Research Institutes | Indole compounds |
| FR2884251B1 (fr) * | 2005-04-08 | 2007-07-13 | Servier Lab | Derives de piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| WO2015066344A1 (en) | 2013-11-01 | 2015-05-07 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists and compositions and methods of use |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK181190D0 (da) * | 1990-07-30 | 1990-07-30 | Lundbeck & Co As H | 3-aryl-indol- eller 3-aryl-indazolderivater |
| TW270114B (no) * | 1993-10-22 | 1996-02-11 | Hoffmann La Roche | |
| DE19500689A1 (de) * | 1995-01-12 | 1996-07-18 | Merck Patent Gmbh | Indolpiperidin-Derivate |
| US5912256A (en) * | 1996-06-20 | 1999-06-15 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
| JP3560986B2 (ja) * | 1997-01-13 | 2004-09-02 | 山之内製薬株式会社 | ５―ｈｔ２ｃ受容体作用薬及びアミノアルキルインダゾール誘導体 |
-
1999
- 1999-01-26 FR FR9900801A patent/FR2788772B1/fr not_active Expired - Fee Related
-
2000
- 2000-01-24 JP JP14544A patent/JP2000212162A/ja active Pending
- 2000-01-24 CA CA002297279A patent/CA2297279C/fr not_active Expired - Fee Related
- 2000-01-25 AU AU13553/00A patent/AU761084B2/en not_active Ceased
- 2000-01-25 MX MXPA00000856A patent/MXPA00000856A/es not_active IP Right Cessation
- 2000-01-25 EA EA200000068A patent/EA003146B1/ru not_active IP Right Cessation
- 2000-01-25 NZ NZ502494A patent/NZ502494A/en unknown
- 2000-01-25 KR KR10-2000-0003388A patent/KR100445389B1/ko not_active Expired - Fee Related
- 2000-01-25 US US09/490,909 patent/US6239129B1/en not_active Expired - Fee Related
- 2000-01-25 NO NO20000373A patent/NO314801B1/no unknown
- 2000-01-25 PL PL00338027A patent/PL338027A1/xx not_active Application Discontinuation
- 2000-01-25 BR BR0000158-9A patent/BR0000158A/pt not_active IP Right Cessation
- 2000-01-26 DK DK00400193T patent/DK1023898T3/da active
- 2000-01-26 HU HU0000308A patent/HUP0000308A2/hu unknown
- 2000-01-26 CN CNB001011561A patent/CN1155570C/zh not_active Expired - Fee Related
- 2000-01-26 DE DE60001591T patent/DE60001591T2/de not_active Expired - Fee Related
- 2000-01-26 EP EP00400193A patent/EP1023898B1/fr not_active Expired - Lifetime
- 2000-01-26 ZA ZA200000336A patent/ZA200000336B/xx unknown
- 2000-01-26 AT AT00400193T patent/ATE234093T1/de not_active IP Right Cessation
- 2000-01-26 SI SI200030063T patent/SI1023898T1/xx unknown
- 2000-01-26 ES ES00400193T patent/ES2193923T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2297279A1 (fr) | 2000-07-26 |
| FR2788772A1 (fr) | 2000-07-28 |
| PL338027A1 (en) | 2000-07-31 |
| HK1029584A1 (en) | 2001-04-06 |
| BR0000158A (pt) | 2000-09-19 |
| ATE234093T1 (de) | 2003-03-15 |
| EA200000068A3 (ru) | 2000-10-30 |
| FR2788772B1 (fr) | 2001-03-02 |
| ES2193923T3 (es) | 2003-11-16 |
| HUP0000308A2 (en) | 2002-06-29 |
| NZ502494A (en) | 2001-06-29 |
| CN1155570C (zh) | 2004-06-30 |
| ZA200000336B (en) | 2000-08-15 |
| DE60001591T2 (de) | 2003-12-24 |
| SI1023898T1 (en) | 2003-06-30 |
| JP2000212162A (ja) | 2000-08-02 |
| NO20000373D0 (no) | 2000-01-25 |
| EA200000068A2 (ru) | 2000-08-28 |
| KR100445389B1 (ko) | 2004-08-25 |
| AU761084B2 (en) | 2003-05-29 |
| AU1355300A (en) | 2000-07-27 |
| DE60001591D1 (de) | 2003-04-17 |
| EP1023898B1 (fr) | 2003-03-12 |
| MXPA00000856A (es) | 2002-03-08 |
| HU0000308D0 (en) | 2000-03-28 |
| KR20010006587A (ko) | 2001-01-26 |
| EP1023898A1 (fr) | 2000-08-02 |
| CA2297279C (fr) | 2004-05-18 |
| EA003146B1 (ru) | 2003-02-27 |
| NO314801B1 (no) | 2003-05-26 |
| DK1023898T3 (da) | 2003-06-10 |
| US6239129B1 (en) | 2001-05-29 |
| CN1266057A (zh) | 2000-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP055644A (es) | Derivados de la quinolil-propil-piperidina y su utilización | |
| NO981415L (no) | Nye N-arylpiperidin-forbindelser, en fremgangsmåte ved fremstilling derav og farmasöytiske preparater inneholdende slike | |
| AU9079198A (en) | Indolecarboxylic compounds and their use as pharmaceutical compounds | |
| NO20000373L (no) | Nye cyano-indol serotinin-reopptaks-inhibitorforbindelser, fremgangsmÕte for deres fremstilling og farmasøytiske sammensetninger inneholdende dem | |
| AR049418A1 (es) | Derivados de heteroarilaminopirazol y composiciones farmaceuticas para el tratamiento de la diabetes. | |
| PT1216245E (pt) | Derivados sulfonil-hidrazida farmaceuticamente activos | |
| NO20016389L (no) | Fremgangsmåte for fremstilling av substituerte cyklopentanderivater og nye krystallinske strukturer derav | |
| NO20082226L (no) | 6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav | |
| BR0208823A (pt) | Composto, método de tratamento de distúrbios que são remediados ou aliviados pela atividade de agonista de vasopressina em um mamìfero necessitando do mesmo, e, composição farmacêutica | |
| NO20002351D0 (no) | Nye substituerte pyridin- eller piperidinforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem | |
| EP0705816A4 (en) | BENZENE DERIVATIVES, SUITABLE FOR ISCHEMIC DISEASES | |
| NO984007L (no) | Nye disubstituerte trans-3,4,4a,5,6,10b-heksahydro-2H-naft[1,2-b]-1,4-oksaziner, en fremgangsmÕte ved deres fremstilling og farmas°ytiske sammensetninger inneholder disse | |
| NO20002315L (no) | Nye 1-aza-2-alkyl-6-aryl-cykloalkanforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem | |
| NO20051794L (no) | Fremgangsmate for fremstilling av epotilonderivater, og nye mellomprodukter for fremgangsmaten, samt fremgangsmater for fremstilling av slike | |
| NO20045540L (no) | Nye 3-(4-okso-4H-kromen-2-yl)-(1H)-kinolin-4-on-forbindelser, en fremgangsmate for deres fremstilling og farmasoytisk sammensetninger inneholdende dem | |
| NO955071D0 (no) | abeo-Ergolin-derivater som 5HT1A-ligander | |
| UA89619C2 (ru) | Соединения пиперазина, способ их получения и фармацевтическая композиция, которая их содержит | |
| DK1572198T3 (da) | Farmaceutiske forbindelser med alfa2-receptoraktivitet | |
| AR037068A1 (es) | Procedimiento para preparar compuestos de 10,11-metanodibenzosuberano y sales farmaceuticamente aceptables de los mismos; metodo para preparar compuestos intermediarios de aplicacion en dicho procedimiento;triclorhidratos cristalinos de (2r)-anti-5-{3-[4-(10,11-difluorometanodibenzo-5-il)piperacin-1 | |
| NO303494B1 (no) | Tetrahydronaftalenderivater, fremgangsmÕte for deres fremstilling og farmas°ytisk preparat inneholdende et slikt derivat, samt mellomprodukter | |
| DK0570263T3 (da) | Hidtil ukendte alkencarboxylsyrederivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder |